title: Expression and potential clinical significance of urothelial cytodifferentiation markers in the exstrophic bladder.
abstract: OBJECTIVE
  We characterize the urothelium from patients with classic bladder exstrophy-epispadias complex for the expression of proteins associated with urothelial differentiation, and discuss a potential impact of urothelial phenotype on the structural and functional properties of the bladder template following bladder closure.
  
  
  METHODS
  From 2005 to 2010 bladder biopsies from 32 infants with bladder exstrophy-epispadias complex obtained at primary bladder closure were collected. After histological assessment immunochemistry was used to investigate the expression of uroplakin IIIa, cytokeratin differentiation restricted antigens CK13 and CK20, and tight junction protein claudin 4.
  
  
  RESULTS
  Overall tissue morphology showed gross alterations with inflammatory, proliferative and metaplastic changes in most specimens. Sections of intact epithelium were present in 78% of biopsies. With respect to urothelial phenotype, CK13 was expressed in all specimens, whereas UPIIIa and CK20 were absent in 76% of the tissues examined. Of the biopsies 52% revealed an irregular expression pattern of tight junction protein Cl-4.
  
  
  CONCLUSIONS
  This is the first study to our knowledge to characterize the urothelium from infants with bladder exstrophy-epispadias complex for the expression of urothelial differentiation associated antigens. Our findings suggest urothelial differentiation changes in a majority of exstrophic bladders, at least at primary bladder closure. Although the underlying etiology remains to be established, abnormal urothelial differentiation may result in a dysfunctional urothelial barrier with implications for the structural and functional properties of the bladder template. Despite the study limitations, our preliminary findings provide a platform for further investigation of the significance of the urothelium for the exstrophic bladder.
authors.affiliation: Department of Pediatric Urology, University Medical Center Regensburg, Regensburg, Germany. peterchristian.rubenwolf@barmherzige-regensburg.de
authors.forename: Peter C
authors.initials: PC
authors.lastname: Rubenwolf
authors.forename: Fabian
authors.initials: F
authors.lastname: Eder
authors.forename: Anne-Karoline
authors.initials: AK
authors.lastname: Ebert
authors.forename: Ferdinand
authors.initials: F
authors.lastname: Hofstaedter
authors.forename: Wolfgang H
authors.initials: WH
authors.lastname: Roesch
mesh_terms: D000943:Antigens, Differentiation / Q000378:metabolism; D001746:Bladder Exstrophy / Q000453:epidemiology / Q000378:metabolism*; D002454:Cell Differentiation; D062506:Claudin-4 / Q000378:metabolism; D004842:Epispadias / Q000453:epidemiology; D006801:Humans; D007150:Immunohistochemistry; D007231:Infant, Newborn; D053535:Keratin-13 / Q000276:immunology; D053554:Keratin-20 / Q000276:immunology; D060171:Uroplakin III / Q000378:metabolism; D019459:Urothelium / Q000166:cytology
chemical_list: D000943:Antigens, Differentiation; C568157:CLDN4 protein, human; D062506:Claudin-4; D053535:Keratin-13; D053554:Keratin-20; D060171:Uroplakin III